VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
NASDAQ:VMD - Nasdaq - CA92663R1055 - Common Stock - Currency: USD
Taking everything into account, VMD scores 6 out of 10 in our fundamental rating. VMD was compared to 103 industry peers in the Health Care Providers & Services industry. VMD has only an average score on both its financial health and profitability. VMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VMD suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year VMD was profitable.
VMD had a positive operating cash flow in the past year.
VMD had positive earnings in each of the past 5 years.
Each year in the past 5 years VMD had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 6.90%, VMD belongs to the best of the industry, outperforming 85.44% of the companies in the same industry.
The Return On Equity of VMD (9.12%) is better than 71.84% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.48%, VMD is in the better half of the industry, outperforming 73.79% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for VMD is below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.9% | ||
| ROE | 9.12% | ||
| ROIC | 7.48% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
VMD has a better Profit Margin (5.28%) than 77.67% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
With a decent Operating Margin value of 6.47%, VMD is doing good in the industry, outperforming 66.99% of the companies in the same industry.
VMD's Operating Margin has declined in the last couple of years.
VMD has a better Gross Margin (58.71%) than 80.58% of its industry peers.
VMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.47% | ||
| PM (TTM) | 5.28% | ||
| GM | 58.71% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VMD is destroying value.
Compared to 1 year ago, VMD has more shares outstanding
VMD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, VMD has an improved debt to assets ratio.
2.2 Solvency
VMD has an Altman-Z score of 5.94. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.94, VMD belongs to the best of the industry, outperforming 88.35% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that VMD is not too dependend on debt financing.
VMD has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. VMD outperforms 80.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.94 |
ROIC/WACC0.82
WACC9.14%
2.3 Liquidity
A Current Ratio of 1.38 indicates that VMD should not have too much problems paying its short term obligations.
The Current ratio of VMD (1.38) is comparable to the rest of the industry.
A Quick Ratio of 1.26 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a Quick ratio (1.26) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.26 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.38% over the past year.
VMD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.01% yearly.
Looking at the last year, VMD shows a quite strong growth in Revenue. The Revenue has grown by 19.97% in the last year.
Measured over the past years, VMD shows a very strong growth in Revenue. The Revenue has been growing by 22.80% on average per year.
EPS 1Y (TTM)15.38%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%50%
Revenue 1Y (TTM)19.97%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%16.87%
3.2 Future
The Earnings Per Share is expected to grow by 31.47% on average over the next years. This is a very strong growth
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.97% yearly.
EPS Next Y33.46%
EPS Next 2Y42.13%
EPS Next 3Y31.47%
EPS Next 5YN/A
Revenue Next Year16.47%
Revenue Next 2Y14.66%
Revenue Next 3Y11.97%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.63, VMD is valued on the expensive side.
VMD's Price/Earnings ratio is a bit cheaper when compared to the industry. VMD is cheaper than 64.08% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.54. VMD is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 11.47 indicates a reasonable valuation of VMD.
Based on the Price/Forward Earnings ratio, VMD is valued cheaper than 81.55% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (36.44), we can say VMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.63 | ||
| Fwd PE | 11.47 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VMD indicates a rather cheap valuation: VMD is cheaper than 88.35% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.14 |
4.3 Compensation for Growth
VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
VMD's earnings are expected to grow with 31.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)5.39
EPS Next 2Y42.13%
EPS Next 3Y31.47%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.49
-0.18 (-2.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners64.91%
Inst Owner ChangeN/A
Ins Owners12.97%
Ins Owner Change5.16%
Market Cap256.48M
Analysts80
Price Target13.26 (104.31%)
Short Float %1.12%
Short Ratio2.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.35%
Min EPS beat(2)-5.7%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)-4.53%
Min EPS beat(4)-43.42%
Max EPS beat(4)32.01%
EPS beat(8)2
Avg EPS beat(8)-9.01%
EPS beat(12)3
Avg EPS beat(12)-11.79%
EPS beat(16)5
Avg EPS beat(16)-5.78%
Revenue beat(2)1
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)0.24%
Revenue beat(4)3
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)1.15%
Revenue beat(8)6
Avg Revenue beat(8)0.15%
Revenue beat(12)9
Avg Revenue beat(12)0.31%
Revenue beat(16)12
Avg Revenue beat(16)1.02%
PT rev (1m)0%
PT rev (3m)1.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.63 | ||
| Fwd PE | 11.47 | ||
| P/S | 1.1 | ||
| P/FCF | N/A | ||
| P/OCF | 6.29 | ||
| P/B | 1.9 | ||
| P/tB | 2.54 | ||
| EV/EBITDA | 6.14 |
EPS(TTM)0.3
EY4.62%
EPS(NY)0.57
Fwd EY8.71%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)1.03
OCFY15.89%
SpS5.89
BVpS3.41
TBVpS2.55
PEG (NY)0.65
PEG (5Y)5.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.9% | ||
| ROE | 9.12% | ||
| ROCE | 10.56% | ||
| ROIC | 7.48% | ||
| ROICexc | 8.05% | ||
| ROICexgc | 10.81% | ||
| OM | 6.47% | ||
| PM (TTM) | 5.28% | ||
| GM | 58.71% | ||
| FCFM | N/A |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexcg growth 3Y2.65%
ROICexcg growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.09 | ||
| Cap/Depr | 183.87% | ||
| Cap/Sales | 20.3% | ||
| Interest Coverage | 17.69 | ||
| Cash Conversion | 100.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.26 | ||
| Altman-Z | 5.94 |
F-Score8
WACC9.14%
ROIC/WACC0.82
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%50%
EPS Next Y33.46%
EPS Next 2Y42.13%
EPS Next 3Y31.47%
EPS Next 5YN/A
Revenue 1Y (TTM)19.97%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%16.87%
Revenue Next Year16.47%
Revenue Next 2Y14.66%
Revenue Next 3Y11.97%
Revenue Next 5YN/A
EBIT growth 1Y-2.82%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year209.91%
EBIT Next 3Y61.39%
EBIT Next 5YN/A
FCF growth 1Y-186.63%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y31.09%
OCF growth 3Y20.23%
OCF growth 5Y15.41%